Seller navigates turbulence to net $30m in Bloomage sale

Yong Rong Global Excellence Fund managed to navigate choppy conditions in Asia’s equity capital markets to exit Bloomage Biotechnology in a HK$231.5m ($30m) block on Monday, July 13, wooing investors eager to take a position in the company at discounted levels.